PepGen Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
PEPG on Nasdaq
Industry
Pharmaceutical Preparations
Location
1 Marina Park Drive, Suite 900, Boston, MA

Insiders trading volume in the past year

PepGen Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ra Capital Management, L.P. Director, 10%+ Owner $59.4M +$30M +102% Sep 26, 2025
Oxford Science Enterprises plc Former 10% Owner $15.9M +$640K +4.21% Sep 30, 2025
James E. Flynn Possible Member of 10% Group, 10%+ Owner $3.97M May 10, 2022
James G. McArthur President and CEO, Director $154K +$61.3K +65.8% Apr 17, 2025
Noel Donnelly Chief Financial Officer $41.9K -$2.57K -5.77% Mar 3, 2025
Paul Streck EVP, Head of R&D $34.5K +$10.4K +43.1% May 30, 2025
Kasra Kasraian Chief Technical Officer $26.8K May 20, 2025
Mary Beth DeLena General Counsel $25.1K -$2.41K -8.73% Mar 3, 2025
Michelle L. Mellion Chief Medical Officer $0 Jul 24, 2024
Niels Svenstrup SVP, Chem. Mfg & Controls $0 May 17, 2024
Christopher Ashton Director Jun 20, 2024
Sonia Bracegirdle Sr. VP Strategy & Operations May 6, 2022
Jaya Goyal EVP, Res. & Preclin. Dev. Mar 24, 2023
Mitchell H. Finer Director Mar 27, 2025
Heidi Henson Director Jun 4, 2025
Laurie Keating Director Jun 4, 2025
Lisa Wyman Director Mar 27, 2025
Habib J. Dable Director Jun 4, 2025
Howard Mayer Director Jun 4, 2025
Joshua Resnick Director Jun 4, 2025

Recent Insider Transactions by Companies or Individuals for PepGen Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.